Miles White

Miles White
Miles White
Type: Person
Name: Miles White (Miles D. White)
Title: Chairman and chief executive officer
Organization: Abbott Laboratories
Date of Birth: 1955
Place of Birth: Minneapolis, Minnesota
Nationality: United States
Fact Sheet: Biography for Miles White
First reported May 03 2013 - Updated May 03 2013 - 1 reports

Richer Than You

As a general rule, the most successful man in life is the man who has the best informationIncome inequality in Canada and the United States is on the rise. Most of the published articles today, as to why income inequality is rising, are dead wrong. Read ... [Published Safe Haven - May 03 2013]
First reported May 03 2013 - Updated May 03 2013 - 2 reports

Abbott Laboratories (ABT) Changes Its Focus

Abbott Laboratories (NYSE: ABT ) ‘  first-quarter earnings were boosted by its nutritional product lines, which include baby formula Similac, adult drink Ensure, and Glucerna bars. In January 2013, the company decided to move away from branded pharmaceuticals, ... [Published InsiderMonkey.com - May 03 2013]
First reported Apr 29 2013 - Updated Apr 29 2013 - 1 reports

Packers fill in the gaps

If you think the 7 round, three day NFL draft is hectic, once Mr. Irrelevant is chosen, war rooms across the league turn to absolute chaos when every available GM and scout grabs a phone to start calling, convincing and signing undrafted college free ... [Published WTAQ News Talk - Apr 29 2013]
First reported Apr 23 2013 - Updated Apr 23 2013 - 1 reports

Health-Care Companies Report Slowdown in Patient Visits

The spike late last year in doctor and hospital visits apparently lasted as long as the flu.After years of decelerating health-care usage--linked to economic problems in the U.S. and Europe--the recent uptick increased optimism that a corner was being ... [Published Capital.gr - Apr 23 2013]
First reported Apr 18 2013 - Updated Apr 18 2013 - 3 reports

Post-pharma Abbott soars on Dx, struggles with devices

Abbott Laboratories CEO Miles WhiteThe new Abbott Laboratories ($ABT) is counting on med tech for revenue growth in a proprietary-drug-free future, and the company is so far succeeding in diagnostics while medical device sales falter.In the first quarter, ... [Published FiercePharma - Apr 18 2013]
First reported Apr 18 2013 - Updated Apr 18 2013 - 1 reports

Abbott reports strong first-quarter growth

Abbott has announced its financial results for the first quarter of the 2013 business year, during which it generated a worldwide sales total of $5.38 billion (3.53 billion pounds).Excluding the impact of foreign exchange rates, this represented a 3.5 ... [Published Zenopa - Apr 18 2013]
First reported Apr 17 2013 - Updated Apr 18 2013 - 1 reports

Abbott Laboratories' CEO Discusses Q1 2013 Results - Earnings Call Transcript

Abbott Laboratories ( ABT ) Q1 2013 Earnings Call April 17, 2013 9:00 a.m. ET Executives Brian Yoor - Vice President of Investor Relations Miles White - Chairman and Chief Executive Officer Tom Freyman - Chief Financial Officer and Executive ... [Published Healthcare Sector and Stocks Analysis from Seek ... - Apr 17 2013]
First reported Apr 17 2013 - Updated Apr 17 2013 - 3 reports

UPDATE: 'New Abbott' Labs Sees Sales Boost From ...

--Abbott's push into emerging markets helps offset slowing growth in the U.S. and Europe--Nutritional products rise 8.7% to $1.69 billion--Medical devices unit falls 4.6%(Updated throughout to add details and company comment.) By Joseph Walker Abbott ... [Published ADVFN UK - Apr 17 2013]
First reported Apr 17 2013 - Updated Apr 17 2013 - 1 reports

Abbott posts strong 1Q earnings

ABBOTT PARK — Abbott Laboratories on Wednesday, April 17, announced solid financial results for the first quarter ended March 31.Abbott, which split off its branded drugs business at the beginning of the year into AbbVie Inc., reported a first-quarter ... [Published Lake County News Sun - Apr 17 2013]
First reported Apr 17 2013 - Updated Apr 17 2013 - 1 reports

Abbott Labs Meets Earnings Estimates; Stock Rises

Posted 11:25 AM ETMedical-product maker Abbott Laboratories (ABT) early Wednesday met expectations in its first quarterly financial report without its proprietary-drug business, with sharply differing results for emerging and developed markets. Shares ... [Published Investors Business Daily - Apr 17 2013]
First reported Apr 17 2013 - Updated Apr 17 2013 - 1 reports

'New' Abbott Fills China's Craving For Baby Formula, Nutrition

In its first quarter as a new company no longer reliant on pharmaceuticals to drive growth, Abbott Laboratories Abbott Laboratories The different look for Abbott comes after the company in January split off its proprietary drug business into AbbVie A ... [Published Forbes.com - Apr 17 2013]

Quotes

"the uptake in europe is taking a little longer than we might like, but we're confident this is going to be a workhorse stent for us over time" White said
...in nutrition and diagnostics, as well as overall results in emerging markets, led our sales growth this quarter," Chief Executive Miles White said. "we had significant new product and geographic expansion activity during the quarter that positions abbott well for continued growth."
"even a bad day in an emerging market looks better than a good day in a developed market" White said in a conference call with analysts
...market in the world," Abbott chairman and chief executive Miles White told Wall Street analysts and investors on a conference call this morning. "the emerging markets are still fairly robust and strong."

More Content

All (21) | News (18) | Reports (2) | Blogs (0) | Audio/Video (0) | Fact Sheets (1) | Press Releases (0)
sort by: Date | Relevance
Richer Than You [Published Safe Haven - May 03 2013]
Income Inequality - Richer Than You [Published Market Oracle - May 03 2013]
Abbott Laboratories (ABT) Changes Its Focus [Published InsiderMonkey.com - May 03 2013]
Abbott Shifts Focus to Nutrition Demand Overseas [Published Motley Fool - May 03 2013]
Packers fill in the gaps [Published WTAQ News Talk - Apr 29 2013]
Health-Care Companies Report Slowdown in Patien... [Published Capital.gr - Apr 23 2013]
Post-pharma Abbott soars on Dx, struggles with ... [Published FiercePharma - Apr 18 2013]
Abbott reports strong first-quarter growth [Published Zenopa - Apr 18 2013]
Abbott closes Q1 with sales boost [Published Medical Marketing And Media - Apr 18 2013]
Abbott's Medical Device Division Struggling [Published QMED - Apr 18 2013]
Abbott Laboratories' CEO Discusses Q1 2013 Resu... [Published Seeking Alpha - Apr 17 2013]
Abbott Laboratories' CEO Discusses Q1 2013 Resu... [Published Healthcare Sector and Stocks Analysis from Seek ... - Apr 17 2013]
UPDATE: 'New Abbott' Labs Sees Sales Boost From... [Published ADVFN UK - Apr 17 2013]
Abbott posts strong 1Q earnings [Published Lake County News Sun - Apr 17 2013]
'New Abbott' Labs Sees Sales Boost From Emergin... [Published 4 Traders - Apr 17 2013]
Abbott Labs Meets Earnings Estimates; Stock Rises [Published Investors Business Daily - Apr 17 2013]
UPDATE 2-Abbott hits mark, but devices, generic... [Published Reuters - Apr 17 2013]
'New' Abbott Fills China's Craving For Baby For... [Published Forbes.com - Apr 17 2013]
Abbott Labs Acquires Piramal’s Healthcare Unit ... [Published Topnews.in - May 22 2010]
Abbott completes Solvay buy [Published Topnews.in - Feb 17 2010]
Biography for Miles White [Published Able2Act - Feb 01 2006]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.